Intramuscular Venous Malformations of the Upper and Lower Limbs: Indications and Outcomes of Sclerotherapy

Cardiovascular and Interventional Radiology
Giuseppe BianchiniSergio Furgiuele

Abstract

Multiple treatment options have been described for intramuscular venous malformations (VMs) of the limbs. At the current time, there are no clear management guidelines. The aim was to evaluate efficacy and safety of sclerotherapy in this type of VMs. This is a single-center, retrospective review of patients treated for extremity intramuscular VMs between January 2013 and June 2017. The primary outcomes were the improvement of symptoms self-assessed by questionnaires, and the reduction in VM size measured by magnetic resonance (MRI). Sclerotherapy was performed in 81 patients with extremity intramuscular VMs. The sclerosing agent was ethanol in 46 cases (56.8%), polidocanol in 27 cases (33.3%), a combination of both in 8 cases (9.9%). The mean follow-up was 26 months (range 3-52). Overall quality of life was improved in 62 patients (76.5%). The postoperative MRI showed a minimum change of VM size in 68 patients (83.9%). A major complication (peripheral nerve injury) was observed in 1 case (1.2% of patients, 0.5% of procedures). Minor complications occurred in 9 cases (11.1% of patients, 4.1% of procedures). Sclerotherapy is a low-invasive, effective and safe treatment for intramuscular VMs of the extremities. It induces a signif...Continue Reading

References

Oct 6, 1999·The Journal of Hand Surgery·J UptonS Pap
Apr 2, 2004·Clinical Orthopaedics and Related Research·Benjamin G DombFrank J Frassica
Dec 31, 2008·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Derick A MendoncaRuth Lester
Jun 2, 2011·Annals of Plastic Surgery·Aladdin H HassaneinArin K Greene
Sep 21, 2011·Journal of Pediatric Surgery·Arin K GreeneSteven J Fishman
Sep 25, 2012·Journal of Vascular and Interventional Radiology : JVIR·David D Childs, Cynthia L Emory
Jan 24, 2013·Annals of Rehabilitation Medicine·Ho Chul JungMyung Kyu Park
Mar 27, 2013·Phlebology·E Rabe, F Pannier
Mar 19, 2013·Techniques in Vascular and Interventional Radiology·Patricia E Burrows
May 18, 2013·Pediatric Dermatology·Sinae A VogelIlona J Frieden
Jun 14, 2013·Vascular and Endovascular Surgery·Yajing QiuGang Ma
Feb 11, 2014·Annals of Vascular Surgery·Stefanie GurgaczN Ann Scott
Sep 4, 2014·ANZ Journal of Surgery·Frederica SteinerSwee T Tan
Dec 19, 2015·Cardiovascular and Interventional Radiology·Carlos J GuevaraMichael D Darcy
Sep 14, 2016·Journal of Pediatric Surgery·Minna M WieckDean M Anselmo
Jan 27, 2017·Cardiovascular Diagnosis and Therapy·Sasan BehraveshRahmi Oklu
Sep 21, 2017·AJR. American Journal of Roentgenology·Veronika I TeuschWibke Uller
Mar 2, 2018·Cardiovascular and Interventional Radiology·Kristina R AsdahlTine Damsgaard

❮ Previous
Next ❯

Citations

May 8, 2020·Phlebology·Claude LaurianUNKNOWN Interdisciplinary Study Group for Vascular Malformations Lariboisière and Saint-Joseph Hospitals
Dec 1, 2020·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Yuming SunShaorong Lei
Aug 21, 2020·Journal of Pediatric Orthopedics·Reuben J ChenAnthony J Penington
Jun 11, 2021·Cardiovascular and Interventional Radiology·Hiroyasu FujiwaraSusumu Kanazawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.